BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19628709)

  • 1. The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
    Klapproth K; Sander S; Marinkovic D; Baumann B; Wirth T
    Blood; 2009 Sep; 114(12):2448-58. PubMed ID: 19628709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myc suppression of Nfkb2 accelerates lymphomagenesis.
    Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
    BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
    Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
    Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
    Han SS; Yun H; Son DJ; Tompkins VS; Peng L; Chung ST; Kim JS; Park ES; Janz S
    Mol Cancer; 2010 Apr; 9():97. PubMed ID: 20433747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
    Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
    den Hollander J; Rimpi S; Doherty JR; Rudelius M; Buck A; Hoellein A; Kremer M; Graf N; Scheerer M; Hall MA; Goga A; von Bubnoff N; Duyster J; Peschel C; Cleveland JL; Nilsson JA; Keller U
    Blood; 2010 Sep; 116(9):1498-505. PubMed ID: 20519624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
    Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
    Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane TNF-alpha mediates "forward" and "reverse" signaling, inducing cell death or survival via the NF-kappaB pathway in Raji Burkitt lymphoma cells.
    Zhang H; Yan D; Shi X; Liang H; Pang Y; Qin N; Chen H; Wang J; Yin B; Jiang X; Feng W; Zhang W; Zhou M; Li Z
    J Leukoc Biol; 2008 Sep; 84(3):789-97. PubMed ID: 18550789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.
    David A; Arnaud N; Fradet M; Lascaux H; Ouk-Martin C; Gachard N; Zimber-Strobl U; Feuillard J; Faumont N
    Haematologica; 2017 May; 102(5):883-894. PubMed ID: 28232371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
    Vega MI; Huerta-Yepez S; Jazirehi AR; Garban H; Bonavida B
    Oncogene; 2005 Dec; 24(55):8114-27. PubMed ID: 16103877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
    Arunkumar N; Liu C; Hang H; Song W
    Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid- and retinoid-mediated growth arrest and apoptosis in WEHI-231 cells: role of NF-kappaB, c-Myc and CKI p27(Kip1).
    Donjerković D; Mueller CM; Scott DW
    Eur J Immunol; 2000 Apr; 30(4):1154-61. PubMed ID: 10760805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth.
    Hart LS; Cunningham JT; Datta T; Dey S; Tameire F; Lehman SL; Qiu B; Zhang H; Cerniglia G; Bi M; Li Y; Gao Y; Liu H; Li C; Maity A; Thomas-Tikhonenko A; Perl AE; Koong A; Fuchs SY; Diehl JA; Mills IG; Ruggero D; Koumenis C
    J Clin Invest; 2012 Dec; 122(12):4621-34. PubMed ID: 23143306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.
    Chin M; Herscovitch M; Zhang N; Waxman DJ; Gilmore TD
    Oncogene; 2009 May; 28(20):2100-11. PubMed ID: 19377508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
    Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
    Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J; Boxer LM
    J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
    Jeong SM; Lee A; Lee J; Haigis MC
    J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis.
    Luciano F; Herrant M; Jacquel A; Ricci JE; Auberger P
    FASEB J; 2003 Apr; 17(6):711-3. PubMed ID: 12586738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.
    Rodig SJ; Kutok JL; Paterson JC; Nitta H; Zhang W; Chapuy B; Tumwine LK; Montes-Moreno S; Agostinelli C; Johnson NA; Ben-Neriah S; Farinha P; Shipp MA; Piris MA; Grogan TM; Pileri SA; Gascoyne RD; Marafioti T
    Haematologica; 2010 Dec; 95(12):2056-62. PubMed ID: 20823132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.